Peri-operative desmopressin combined with pharmacokinetic-guided factor VIII concentrate in non-severe haemophilia A patients.

Lorenzo G R Romano Lisette M SchütteReinier M van HestKarina MeijerBritta A P Laros-van GorkomLaurens NieuwenhuizenJeroen EikenboomFloor C J I Heubel-MoenenNanda UitslagerMichiel CoppensKarin C J FijnvandraatMariëtte H E DriessensSuzanne PolinderMarjon H CnossenFrank W G LeebeekRon A A MathôtMarieke J H A Kruipnull null

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2024)

Peri-operative combination treatment with desmopressin and PK-guided FVIII concentrate dosing in nonsevere haemophilia A is feasible, safe and reduces FVIII consumption.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
combination therapy
smoking cessation